Morgan Stanley Forecasts Strong Price Appreciation for UnitedHealth Group (NYSE:UNH) Stock

Key Points

• Morgan Stanley raised its UnitedHealth Group price target from $529 to $531 and maintained an “overweight” rating, implying roughly 29% upside from the reported share price.
• Analyst sentiment is broadly positive: 20 analysts rate UNH a Buy and eight rate it a Hold, producing a “Moderate Buy” consensus rating and an average price target of $463.93.
• UnitedHealth exceeded quarterly expectations, reporting $4.69 in adjusted EPS versus a $4.14 consensus estimate and $112.70 billion in revenue, though revenue declined 0.4% year over year.

UnitedHealth Group (NYSE:UNH - Get Free Report) had its price objective increased by stock analysts at Morgan Stanley from $529.00 to $531.00 in a report released on Tuesday, Benzinga reports. The firm presently has an "overweight" rating on the healthcare conglomerate's stock. Morgan Stanley's target price suggests a potential upside of 29.26% from the stock's current price.

Other analysts have also recently issued research reports about the stock. Piper Sandler lifted their price objective on shares of UnitedHealth Group from $502.00 to $504.00 and gave the stock an "overweight" rating in a research note on Wednesday, October 14th. TD Cowen restated a "hold" rating and issued a $402.00 price target on shares of UnitedHealth Group in a research report on Thursday, October 15th. HC Wainwright set a $500.00 price target on shares of UnitedHealth Group in a research report on Friday, October 16th. Truist Financial lifted their price target on shares of UnitedHealth Group from $440.00 to $480.00 and gave the company a "buy" rating in a research note on Tuesday, July 14th. Finally, UBS Group reiterated an "outperform" rating on shares of UnitedHealth Group in a report on Tuesday, October 13th. Twenty research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $463.93.

UnitedHealth Group Stock Performance

Shares of UNH opened at $410.81 on Tuesday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78. The firm has a 50-day moving average of $388.57 and a 200-day moving average of $360.79. The company has a market cap of $368.74 billion, a PE ratio of 23.46, a price-to-earnings-growth ratio of 1.51 and a beta of 0.60. UnitedHealth Group has a one year low of $255.96 and a one year high of $461.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, topping the consensus estimate of $4.14 by $0.55. The company had revenue of $112.70 billion during the quarter, compared to the consensus estimate of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The firm's revenue for the quarter was down .4% compared to the same quarter last year. During the same period in the previous year, the company posted $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, equities analysts forecast that UnitedHealth Group will post 20.62 earnings per share for the current year.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the company's stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.19% of the company's stock.

Institutional Trading of UnitedHealth Group

Several institutional investors have recently made changes to their positions in UNH. Midland Wealth Advisors LLC increased its position in shares of UnitedHealth Group by 2.8% during the 3rd quarter. Midland Wealth Advisors LLC now owns 1,063 shares of the healthcare conglomerate's stock valued at $390,000 after purchasing an additional 29 shares during the last quarter. Total Clarity Wealth Management Inc. grew its position in UnitedHealth Group by 20.0% during the third quarter. Total Clarity Wealth Management Inc. now owns 1,574 shares of the healthcare conglomerate's stock valued at $578,000 after buying an additional 262 shares during the period. Lodestar Private Asset Management LLC purchased a new stake in UnitedHealth Group during the third quarter worth about $521,000. Penobscot Investment Management Company Inc. increased its holdings in UnitedHealth Group by 9.8% during the third quarter. Penobscot Investment Management Company Inc. now owns 23,601 shares of the healthcare conglomerate's stock worth $8,663,000 after buying an additional 2,098 shares during the last quarter. Finally, Cahaba Wealth Management Inc. raised its position in UnitedHealth Group by 4.5% in the third quarter. Cahaba Wealth Management Inc. now owns 1,393 shares of the healthcare conglomerate's stock worth $511,000 after acquiring an additional 60 shares during the period. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.